Board of Directors

EXECUTIVE COMMITTEE


David Main, President & CEO, Aquinox Pharmaceuticals (Chairman)


Brad Thompson, President & CEO, Oncolytics Biotech Inc. (Past Chair)


John Helou, President, Pfizer Canada Inc. (Vice Chair)


Vince Lamanna, President, Novo Nordisk Canada Inc. (Treasurer)

Ron Keefe, President & CEO, Biovectra Inc. (Member at Large)


Andrew Casey, President & CEO - BIOTECanada (Secretary)


MEMBERS


Brian Bloom, President, Bloom Burton & Co.

Tony Cruz
, CEO, Transition Therapeutics

Natalie Dakers, CEO, CDRD Ventures Inc.

Michel Fortin, President & CEO, Prevtec Microbia Inc.

Diane Gosselin, President & CEO, CQDM

John Haslam, General Manager, Alexion Pharmaceuticals

Kevin Leshuk, General Manager, Celgene Inc.

Mark Lievonen
, President, Sanofi Pasteur Limited

Hervé
Lilliu, General Manager, UCB Canada

A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada

Gordon McCauley, Partner, Viable Healthworks Corp.

John Norman, Partner, Gowling Lafleur Henderson LLP

Greg Penner, President & CEO, NeoVentures Biotechnology Inc.

Paul Petrelli, President and General Manager, Canada, Biogen Idec. Canada Inc.

Dan Wattier, CEO, ImStar Therapeutics

Partnership Program

Platinum

Biogen Idec

gowlings

Genzyme

Pfizer

vwr

Gold & Silver